These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 11751713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH.
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [Abstract] [Full Text] [Related]

  • 6. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A, Takasaka T, Shibasaki H, Kasuya Y, Kawashima S, Yamada A, Furuta T.
    Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
    [Abstract] [Full Text] [Related]

  • 7. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K, Remer T, Fritsche A, Häring HU, Maser-Gluth C.
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [Abstract] [Full Text] [Related]

  • 8. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K, Remer T, Haupt A, Gallwitz B, Fritsche A, Häring HU, Maser-Gluth C.
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [Abstract] [Full Text] [Related]

  • 9. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [Abstract] [Full Text] [Related]

  • 10. Cortisol metabolism in depressed patients and healthy controls.
    Römer B, Lewicka S, Kopf D, Lederbogen F, Hamann B, Gilles M, Schilling C, Onken V, Frankhauser P, Deuschle M.
    Neuroendocrinology; 2009 Mar; 90(3):301-6. PubMed ID: 19713693
    [Abstract] [Full Text] [Related]

  • 11. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X, Chen F, Zhu C, Lu Y.
    J Pharm Biomed Anal; 2015 Mar 25; 107():450-5. PubMed ID: 25668797
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.
    Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ, Schorr U, Sharma AM.
    J Clin Endocrinol Metab; 1999 Oct 25; 84(10):3745-9. PubMed ID: 10523024
    [Abstract] [Full Text] [Related]

  • 13. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
    Vogt B, Dick B, N'Gankam V, Frey FJ, Frey BM.
    J Clin Endocrinol Metab; 1999 Feb 25; 84(2):811-4. PubMed ID: 10022459
    [Abstract] [Full Text] [Related]

  • 14. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
    Stiefel P, García-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A.
    Endocrine; 2002 Aug 25; 18(3):279-84. PubMed ID: 12450320
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activity in healthy men.
    Kerstens MN, van der Kleij FG, Boonstra AH, Sluiter WJ, van der Molen JC, Navis G, Dullaart RP.
    Kidney Int; 2004 Jun 25; 65(6):2065-70. PubMed ID: 15149319
    [Abstract] [Full Text] [Related]

  • 18. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN, Riemens SC, Sluiter WJ, Pratt JJ, Wolthers BG, Dullaart RP.
    Clin Endocrinol (Oxf); 2000 Apr 25; 52(4):403-11. PubMed ID: 10762282
    [Abstract] [Full Text] [Related]

  • 19. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct 25; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 20. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
    N'Gankam V, Uehlinger D, Dick B, Frey BM, Frey FJ.
    Kidney Int; 2002 May 25; 61(5):1859-66. PubMed ID: 11967038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.